Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 15 mg) of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder
Status: Archived
mi
from
Ogden, UT
Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 15 mg) of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Ogden, UT
Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 15 mg) of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder
Status: Archived
mi
from
Milwaukee, WI
Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 15 mg) of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Milwaukee, WI
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Birmingham, AL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 010
mi
from
Birmingham, AL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Little Rock, AR
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 002
mi
from
Little Rock, AR
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Escondido, CA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 01
mi
from
Escondido, CA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Bothell, WA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 014
mi
from
Bothell, WA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Ft. Lauderdale, FL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 006
mi
from
Ft. Lauderdale, FL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Fort Lauderdale, FL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative site 017
mi
from
Fort Lauderdale, FL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Pembroke Pines, FL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative site 005
mi
from
Pembroke Pines, FL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Honolulu, HI
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 013
mi
from
Honolulu, HI
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Atlanta, GA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 009
mi
from
Atlanta, GA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Chicago, IL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative site 016
mi
from
Chicago, IL
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
New Orleans, LA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 004
mi
from
New Orleans, LA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Bronx, NY
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 011
mi
from
Bronx, NY
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Cedarhurst, NY
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 008
mi
from
Cedarhurst, NY
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Riverside, CA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 005
mi
from
Riverside, CA
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Dayton, OH
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 013
mi
from
Dayton, OH
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Littleton, CO
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 20
mi
from
Littleton, CO
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Memphis, TN
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Dallas, TX
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 010
mi
from
Dallas, TX
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
mi
from
Middleton, WI
Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 007
mi
from
Middleton, WI
Rapid Antidepressant Effects of Ketamine in Major Depression
Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Rapid Antidepressant Effects of Ketamine in Major Depression
Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood Disorders
The Effects of Mood and Tryptophan Depletion on the Neural Correlates of Affective Shifting in Mood Disorders
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood Disorders
The Effects of Mood and Tryptophan Depletion on the Neural Correlates of Affective Shifting in Mood Disorders
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of Infliximab for Treatment Resistant Major Depression
An Evaluation of the Efficacy of the Tumor Necrosis Factor-alpha Antagonist Infliximab in Treatment Resistant Major Depression: Mechanisms and Mediators
Status: Enrolling
Updated:  12/31/1969
mi
from
Atlanta, GA
A Study of Infliximab for Treatment Resistant Major Depression
An Evaluation of the Efficacy of the Tumor Necrosis Factor-alpha Antagonist Infliximab in Treatment Resistant Major Depression: Mechanisms and Mediators
Status: Enrolling
Updated: 12/31/1969
Emory Clinic, Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia
A Pilot Study of Transcranial Magnetic Stimulation (TMS) Effects on Pain and Depression in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/31/1969
mi
from
Charleston, SC
A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia
A Pilot Study of Transcranial Magnetic Stimulation (TMS) Effects on Pain and Depression in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Neurocognitive Outcomes of Depression in the Elderly
Clinical Studies of Mental Illness Not Involving Treatment Development, Efficacy, or Effectiveness Trials Phenotype-genotype Predictors of Cognitive Outcomes in Geriatric Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Durham, NC
Neurocognitive Outcomes of Depression in the Elderly
Clinical Studies of Mental Illness Not Involving Treatment Development, Efficacy, or Effectiveness Trials Phenotype-genotype Predictors of Cognitive Outcomes in Geriatric Depression
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
Status: Enrolling
Updated:  12/31/1969
mi
from
Providence, RI
Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
Status: Enrolling
Updated: 12/31/1969
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Colton, CA
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Shanti Clinical Trials
mi
from
Colton, CA
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Mission Viejo, CA
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
A.D.D. Treatment Center
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Stanford, CA
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Stanford, CA
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Veteran Affairs/Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Tarzana, CA
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Center for Healing the Human Spirit
mi
from
Tarzana, CA
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Miami, FL
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Englewood Cliffs, NJ
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Brain Resource Center
mi
from
Englewood Cliffs, NJ
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Brain Resource Center
mi
from
New York, NY
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
White Plains, NY
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical College
mi
from
White Plains, NY
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Columbus, OH
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Providence, RI
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
NeuroDevelopment Center
mi
from
Providence, RI
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Westmead,
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Brain Dynamics Centre
mi
from
Westmead,
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
University of Missouri - St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Asheville, NC
International Study to Predict Optimised Treatment - in Depression
International Study to Predict Optimised Treatment - in Depression
Status: Enrolling
Updated: 12/31/1969
Skyland Behavioral Health Associates , P.A.
mi
from
Asheville, NC
Click here to add this to my saved trials
p11 Protein Levels in Patients With Major Depressive Disorder Treated With Citalopram
An Investigation to Determine Whether Levels of P11 Protein in Peripheral Blood Cells Correlate With Treatment Response to Citalopram in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
p11 Protein Levels in Patients With Major Depressive Disorder Treated With Citalopram
An Investigation to Determine Whether Levels of P11 Protein in Peripheral Blood Cells Correlate With Treatment Response to Citalopram in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
Improving the Effectiveness of Treatment for Depression in Hispanics
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
Improving the Effectiveness of Treatment for Depression in Hispanics
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Using Neuroimaging to Investigate Major Depressive Disorder
Using Neuroimaging to Investigate Neurobiological Correlates of Treatment Resistance Associated With Co-morbid Anxiety in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Dallas, TX
Using Neuroimaging to Investigate Major Depressive Disorder
Using Neuroimaging to Investigate Neurobiological Correlates of Treatment Resistance Associated With Co-morbid Anxiety in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
Status: Enrolling
Updated:  12/31/1969
mi
from
CHapel Hill, NC
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
Status: Enrolling
Updated: 12/31/1969
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression
GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression
GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
Status: Enrolling
Updated:  12/31/1969
mi
from
Dallas, TX
A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
Status: Enrolling
Updated: 12/31/1969
Family and Community Medicine Clinic, University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
fMRI Study of Treatment Changes in Major Depression
fMRI Studies of Emotional Circuitry in Major Depression: Treatment Changes
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
fMRI Study of Treatment Changes in Major Depression
fMRI Studies of Emotional Circuitry in Major Depression: Treatment Changes
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Motivational Interviews for Depression in Primary Care
Motivational Interviews Adapted to Improve Depression Treatment in Primary Care
Status: Enrolling
Updated:  12/31/1969
mi
from
Denver, CO
Motivational Interviews for Depression in Primary Care
Motivational Interviews Adapted to Improve Depression Treatment in Primary Care
Status: Enrolling
Updated: 12/31/1969
Denver Health and Hospital Authority
mi
from
Denver, CO
Click here to add this to my saved trials
Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/Day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Birmingham, AL
Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/Day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials